Helsinn Healthcare SA

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
    • Nutraceuticals
    • Specialty Pharmaceuticals
  • Medical Devices
  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Distributors

Other Names/Subsidiaries

  • Sapphire Therapeutics
  • Helsinn Pharmaceuticals Beijing Co. Ltd.
See more in Biomedtracker

Latest on Helsinn Healthcare SA

Pink Sheet

US FDA Cites Taiho’s Lytgobi Healthcare Provider Website For Misleading Efficacy Claims

 
• By Sue Sutter

A single-arm study cannot provide interpretable results supporting promotional claims for progression-free survival or overall survival, the US Food and Drug Administration said in an advertising and

Scrip

Asia Deal Watch: Chugai Extends Relationship With Helsinn

 
• By Joseph Haas, Vibha Ravi, Dexter Jie Yan, Lisa Takagi, and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Helsinn Extends Akynzeo Marketing

Scrip

Deal Watch: Vanda Gets Competing Offer From Cycle After Unsolicited Future Pak Bid

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cycle Offers $466m For Vanda, Which Tur

Scrip

Oncology Reinvents Itself To Retain Position As Biotech Investors’ Darling

 
• By James Drew

While venture investment in oncology biotechs may have been losing ground to other therapeutic areas in recent years, this is more of a righting of the ship rather than a full blown mid-life crisis. T